Insider Trading & Ownership - Kaufmann Gunnar F.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kaufmann Gunnar F.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-06-12
Purchase
2023-06-14
4:00 pm
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
28,000$0.35086$9,82494,726
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-21
Option Award
2023-02-23
8:00 pm
N/A
2033-02-21
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
210,000$0210,000
(Direct)
View
2023-01-03
Tax Withholding
2023-01-05
6:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
6,266$1.0266,726
(Direct)
View
2022-07-28
Option Award
2022-08-01
6:21 pm
N/A
2032-07-28
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
71,875$0101,742
(Direct)
View
2022-01-20
Option Award
2022-01-24
4:00 pm
N/A
2032-01-20
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
162,457$0162,457
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
29,867$029,867
(Direct)
View
2021-02-11
Option Award
2021-02-16
6:00 pm
N/A
2031-02-11
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
253,000$0253,000
(Direct)
View
2020-03-17
Option Award(A)
2020-07-31
9:06 pm
N/A
2030-03-17
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
14,260$014,260
(Direct)
View
2020-03-17
Option Award
2020-03-18
6:49 pm
N/A
2030-03-17
Oncternal Therapeutics Inc.ONCTKaufmann Gunnar F.
Chief Scientific Officer
14,260$014,260
(Direct)
View
(A) Indicate amendment filing.